Resting energy expenditure and its determinants in hemodialysis patients by Kamimura, Maria Ayako et al.
ORIGINAL ARTICLE
Resting energy expenditure and its determinants in
hemodialysis patients
MA Kamimura1, SA Draibe2, CM Avesani1, MEF Canziani2, FAB Colugnati1 and L Cuppari1,2
1Nutrition Program, Federal University of Sa˜o Paulo, Sa˜o Paulo, Brazil and 2Division of Nephrology, Federal University of Sa˜o Paulo,
Sa˜o Paulo, Brazil
Objective: Chronic kidney disease is associated with several metabolic disturbances that can affect energy metabolism. As
resting energy expenditure (REE) is scarcely investigated in patients on hemodialysis (HD) therapy, we aimed to evaluate the REE
and its determinants in HD patients.
Design: Cross-sectional study.
Setting: Dialysis Unit of the Nephrology Division, Federal University of Sa˜o Paulo, Brazil.
Subjects: The study included 55 patients (28 male, 41.4712.6 years old) undergoing HD therapy thrice weekly for at least 2
months, and 55 healthy individuals pair matched for age and gender. Subjects underwent fasting blood tests, as well as
nutritional assessment, and the REE was assessed by indirect calorimetry.
Results: REE of HD patients was similar to that of pair-matched controls (13797272 and 14407259 kcal/day, respectively),
even when adjusted for fat-free mass (P¼0.24). REE of HD patients correlated positively with fat-free mass (r¼ 0.74; Po0.001)
and body mass index (r¼0.37; Po0.01), and negatively with dialysis adequacy (r¼0.46; Po0.001). No significant univariate
correlation was found between REE and age, dialysis vintage, serum creatinine, urea, albumin, bicarbonate, parathyroid
hormone (PTH) or high-sensitivity C-reactive protein (CRP). In the multiple linear regression analysis, using REE as dependent
variable, the final model showed that besides the well-recognized determinants of REE such as fat-free mass and age, PTH and
CRP were the independent determinants of REE in HD patients (R2¼ 0.64).
Conclusions: In this study, the REE of HD patients was similar to that of healthy individuals, even with the positive effect of
secondary hyperparathyroidism and inflammation on REE of these patients.
Sponsorship: The study was supported by grants from Fundac¸a˜o de Amparo a` Pesquisa do Estado de Sa˜o Paulo (FAPESP) and
Oswaldo Ramos Foundation.
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Introduction
Resting energy expenditure (REE) is the major component of
human total energy expenditure accounting for 60–75% of
variations (Institute of Medicine/Food and Nutrition Board,
2002). The determination of REE is important for the
establishment of energy recommendations and maintenance
of nutritional balance of the individuals (Cuppari and
Avesani, 2004). Elevated REE has been pointed out as a
contributory factor for cachexia in several disease conditions
(Riley et al., 1991; Falconer et al., 1994) and an association
with mortality has been suggested (Wang et al., 2004).
However, little is known about REE and its determinants in
chronic kidney disease (CKD) patients undergoing hemodia-
lysis (HD). Actually, few studies have evaluated the REE of
dialysis patients. Two decades ago, Monteon et al. (1986)
have first examined the REE of chronic HD patients showing
that REE was not different from that of healthy controls. Ten
years later, however, a study by Ikizler et al. (1996) reported a
significant increased REE in HD patients (15–20% during
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dialysis session and 7.5% in the interdialytic day) compared
with control subjects. Uremia per se and the dialysis
procedure are associated with some metabolic derangements
such as metabolic acidosis, insulin resistance and inflamma-
tion, that augment protein catabolism (Mitch et al., 1999)
and could in turn contribute to the variations of REE.
Accordingly, it has been shown that nondialysis CKD
patients with poorly controlled diabetes (Avesani et al.,
2001) and HD patients with severe hyperparathyroidism
(Cuppari et al., 2004) have increased REE. Inflammation is a
highly prevalent condition among CKD patients. Cross-
sectional studies have shown that 30–50% of nondialysis
(Ortega et al., 2002) and dialysis (Docci et al., 1990; McIntyre
et al., 1997) patients present serologic evidence of an
activated inflammatory response with elevated serum con-
centration of C-reactive protein (CRP). Our group has
recently reported increased REE in nondialysis patients
with CRP40.5 mg/dl (Avesani et al., 2004a). When we
extended our investigation into the relationship among
infection, inflammation and REE, it was shown that after
treatment of infection/inflammation a significant decrease
in CRP was accompanied by a 13% reduction of REE (Utaka
et al., 2005).
If on the one hand HD patients are exposed to several
catabolic conditions that may directly affect REE, on the
other renal failure might be associated with hypometabolic
state owing to altered cell metabolism (Om and Hohenegger,
1980) and lower oxygen consumption by the kidney (Kurnik
et al., 1992). Thus, considering that the factors affecting REE
of HD population are not fully understood, we aimed to
compare the REE of HD patients with that of pair-matched
healthy individuals, and to evaluate the determinants of REE
in these particular patients.
Subjects and methods
Patients
Patients were recruited from the Dialysis Unit of the Federal
University of Sa˜o Paulo (Sa˜o Paulo, SP, Brazil). Fifty-five HD
patients (28 men and 27 women) older than 18 years,
without altered thyroid function and/or presence of malig-
nance, were included in the study protocol. Diabetes was an
exclusion criterion; however, two well-controlled diabetic
patients with normal serum glucose level were included.
Patients were dialyzed 4 h thrice weekly for at least 2 months.
The majority of the patients were using iron saccharate and
vitamin complex and none was using hormone, cortico-
steroid or immunosuppressive drugs. The selected patients
were gender and age pair matched (matching limits for age
were 73 years) with a group of 55 healthy individuals.
Control subjects, most of them clinic employees, had normal
renal and thyroid functions, and none was taking medication.
The study was approved by the University Ethical Advisory
Committee and all subjects gave informed consent.
Study design and protocol
In this cross-sectional study, the REE of HD patients was
compared to that of control subjects. In the HD group, the
indirect calorimetry and blood tests were carried out on
interdialytic day, whereas nutritional assessment was per-
formed postdialysis session (15–30 min) in the day before the
calorimetry. Control group underwent fasting blood tests, as
well as nutritional assessment, in the same day of the
indirect calorimetry test.
Anthropometry and body composition
Subjects were weighed with light clothes and without shoes
on a platform manual scale balance (Filizola, Sa˜o Paulo,
Brazil). Body mass index (BMI) was calculated as body weight
divided by squared height. Fat-free mass and body water
were assessed by bioelectrical impedance analysis using a
single-frequency tetrapolar technique with an electrical
current of 800 mA at 50 kHz (BIA 101 Quantum, RJL Systems,
Detroit, MI, USA). The electrodes were placed in the standard
positions (two electrodes placed on the hand and wrist and
another two positioned on the foot and ankle) in the
opposite side of vascular access, with the subject in supine.
The software Fluids & Nutrition (version 3.0), (RJL Systems,
USA) provided by the manufacturer was used to estimate the
fat-free mass and body water.
Skinfold measurement at four standard sites (biceps,
triceps, subscapular and suprailiac) was performed for
determining body fat, as the method seems to be superior
to bioelectrical impedance analysis for the measurement of
this compartment (Kamimura et al., 2003). Body density was
calculated from the sum of the four skinfold measurements
according to Durnin and Womersley (1974), and the
percentage of body fat was then calculated by Siri’s (1961)
equation.
Resting energy expenditure
REE measurements were obtained by indirect calorimetry
using an open-circuit ventilated computerized metabolic
system (Vmax series 29n; SensorMedics Corp; Yorba Linda,
CA, USA). The oxygen and carbon dioxide sensors were
calibrated before each REE measurement with the use of
mixed reference gases of known composition. All subjects
were previously instructed to refrain from any unusual
physical activity 24 h before the test and to sleep at the
same time as usual in the night before the REE measurement.
They were admitted in the clinic at 08:00 after an overnight
fast of 12 h. After resting for 30 min in a recumbent position,
subjects breathed for 30 min through a clear plastic canopy
over their heads in a quiet dimly lit thermo neutral room.
They were instructed to avoid hyperventilation, fidgeting or
falling asleep during the test. Oxygen consumption and
carbon dioxide production were measured at 1-min intervals
and the mean of the last 20 min were used to calculate the
REE according to the Weir’s equation without using urinary
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urea nitrogen (Weir, 1949). The intra-individual variation
coefficient for REE was 5%.
Laboratory data
In the HD group, serum creatinine and urea were obtained
from the monthly routine examination. Blood samples for
glucose, bicarbonate, thyroid stimulating hormone (TSH),
serum albumin, intact parathyroid hormone (PTH) and high-
sensitivity CRP were drawn just before the indirect calori-
metry test. The control group had serum determination of
creatinine, glucose, TSH and CRP also before the indirect
calorimetry test.
Serum creatinine, urea and glucose were determined using
a standard autoanalyzer. Bicarbonate was measured by an
automated potentiometer (normal range: 23–27 mmol/l),
TSH by immunofluorometric assay (normal range: 0.3–
4.0 mIU/ml), and serum albumin by green bromcresol
method (normal range: 2.5–4.0 g/dl). Intact PTH and high-
sensitivity CRP (inflammatory state: X0.5 mg/dl) were
determined by immunochemiluminescence. Dialysis ade-
quacy was assessed by Kt/V (adequate dialysis Kt/V41.2) as
recommended by the National Kidney Foundation guideline
(2001).
Statistical analysis
Data are expressed as mean7standard deviation or median
and ranges according to the variable distribution. For
comparisons between the HD group and the control group,
the two-tailed paired Student’s t-test and w2 test were used, as
appropriate. Pearson’s or Spearman’s univariate analysis was
used to identify the variables that correlated with REE. In
order to evaluate the factors affecting REE among HD
patients, stepwise multiple linear regression analysis was
applied including those variables that correlated signifi-
cantly with REE or those that might influence REE. As the
use of ratios for adjusting REE for fat-free mass may create
errors and differences between the two groups may be found
when there is no actual difference (Ravussin and Bogardus,
1989), for the comparison of REE between the two groups
REE was adjusted for fat-free mass using multiple linear
regression analysis with robust estimation for the error
structure owing to the matching design of the study
(Kleinbaum et al., 1998). Differences with Po0.05 were
considered statistically significant. The statistical analyses
were conducted using the True Epistat software (Texas, USA,
1995) and Stata Corp software, release 7.0 (TX, USA, 2001).
Results
Demographic, clinical and laboratory characteristics of the
subjects are provided in Table 1. The age of patients ranged
from 19 to 75 years, and the vintage on dialysis therapy
ranged from 2 months to 13 years. Patients were receiving
adequate dialysis dose according to the Kt/V. All subjects had
normal thyroid function. The main etiology of CKD was
hypertensive nephrosclerosis (35%), followed by undeter-
mined causes (31%), chronic glomerulonephritis (11%),
interstitial nephritis (7%) and others (16%). As expected,
HD patients exhibited higher levels of CRP in comparison to
control subjects. Increased CRP levels (defined as CRP
X0.5 mg/dl) were found in 43.6% of the patients. On the
other hand, patients had lower BMI, body fat and fat-free
mass. REE adjusted for fat-free mass did not differ between
HD patients and healthy individuals (Figure 1).
In the HD group, REE correlated positively with fat-free
mass (r¼0.74; Po0.001) and BMI (r¼0.37; Po0.01), and
negatively with Kt/V (r¼0.46; Po0.001). No significant
correlation was found between REE and age, dialysis vintage,
Table 1 Demographic, clinical and nutritional characteristics of the
subjects
HD group
(n¼55)
Control group
(n¼55)
P-value
Gender (male/female) 28/27 28/27
Age (years) 41.4712.6 41.5712.5 0.80
Length of dialysis (months) 34.5733.6 —
Kt/V 1.3670.2 —
Serum creatinine (mg/dl) 10.973.2 0.970.2 o0.001
Blood urea nitrogen (mg/dl) 72.9715.8 —
Serum glucose (mg/dl) 92779 82.6716.3 0.37
PTH (pg/ml)a 166.3 (1–2154) —
TSH (mIU/ml) 2.172.2 1.5670.92 0.21
Serum bicarbonate (mmol/l) 23.074.25 —
Serum albumin (g/dl) 4.170.5 —
CRP (mg/dl)a 0.45 (0.01–15) 0.11 (0.02–2.48) o0.001
BMI (kg/m2) 22.572.5 25.173.8 o0.001
Body fat (kg) 14.175.4 19.476.3 o0.001
Body water (%) 54.174.9 52.975.8 0.12
Fat-free mass (kg) 44.979.7 50.1710.7 o0.001
REE (kcal/day) 13797272 14407259 0.11
Abbreviations: BMI, body mass index; CRP, C-reactive protein; HD,
hemodialysis; PTH, parathyroid hormone; REE, resting energy expenditure;
TSH, thyroid stimulating hormone.
Values given as mean and 7standard deviation.
aMedian and range.
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Figure 1 REE in relation to fat-free mass in HD group (m—) and
control group (J– –). Coefficient 40.8 (P¼0.24), confidence
interval 109.7 to 28 kcal.
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serum creatinine, urea, albumin, bicarbonate, PTH or CRP. As
expected, a negative correlation was found between CRP and
albumin (r¼0.36; Po0.01). A direct association of CRP
with age was observed (r¼0.36; Po0.01); however, no
correlation was found between CRP and other laboratory or
nutritional parameters. In the multiple linear regression
analysis using REE as dependent variable, the final model
showed that age, fat-free mass, CRP and PTH were the
independent determinants of REE in HD patients (Table 2).
Discussion
This study showed that REE of HD patients was comparable
to that of age and gender-matched healthy controls. This
finding is in accordance with some investigators (Monteon
et al., 1986; Schneeweiss et al., 1990), but differs from others
who found increased REE in HD patients (Ikizler et al., 1996).
The exact factors affecting REE of CKD patients are not fully
understood, but several mechanisms involving HD patients
may lead to either increase or reduction of REE.
Kidneys have important metabolic functions and perform
a number of oxygen-dependent activities (Silva, 1987). In
healthy individuals, the kidneys account for up to 20% of
the REE (Wang et al., 2004). Hence, renal failure might be
associated with decrease in energy metabolism. In fact,
Kurnik et al. (1992) have demonstrated that patients with
moderate loss of renal function have lower renal blood flow
and lower renal oxygen consumption per kidney than
healthy individuals. Moreover, the profound abnormalities
in cell metabolism that occur in renal failure (Om and
Hohenegger, 1980) and the impaired energy metabolism of
skeletal muscle caused by circulating uremic toxins (Conjard
et al., 1995) may be additional factors contributing to reduce
REE in renal failure patients. Accordingly, studies with CKD
patients not yet on dialysis have recently demonstrated
lower REE than healthy pair-matched controls (O’Sullivan
et al., 2002; Avesani et al., 2004b). In HD patients evaluated
in a nondialysis day, a recent study showed that protein
breakdown and oxidation was considerably reduced com-
pared with control subjects, suggesting lower metabolic
activity in this patient group (Veeneman et al., 2004).
However, REE was not assessed in that study.
In contrast to the possibilities described above, the
comorbid conditions commonly present in CKD are im-
portant contributors for elevating REE in HD patients. The
multiple regression analysis showed that besides the well-
known determinants of REE such as fat-free mass and age,
CRP and PTH were also independent determinants of REE in
HD patients. Inflammation is frequent among CKD patients
and is a powerful predictor of mortality in dialysis patients
(Zimmermann et al., 1999). It has been suggested that low
clearance of CRP and cytokines, uremia itself, hypervolemia
and the presence of comorbidities are possible causes for
inducing the acute-phase reaction in dialysis patients
(Stenvinkel and Yeun, 2004). We found that 43.6% of the
patients (n¼24) had CRP levels of 0.5 mg/dl or greater, a
value considered indicative of an inflammatory condition. A
direct association between inflammatory state and REE has
been reported in other disease conditions such as rheuma-
toid arthritis (Roubenoff et al., 1994), acquired immune
deficiency syndrome (Garcia-Lorda et al., 2000), sepsis
(Chiole´ro et al., 1997) and pancreatic cancer (Falconer
et al., 1994). Recently, our group also demonstrated such
relationship in CKD patients not yet on dialysis (Avesani
et al., 2004a; Utaka et al., 2005). To the best of our
knowledge, this is the first study that evaluated the
association of REE and inflammation in patients undergoing
HD therapy. The exact mechanisms involving inflammation
and REE cannot be fully identified, but it seems reasonable to
speculate that protein catabolism caused by inflammation
might be implicated in the increase of REE. In fact, our HD
patients exhibited elevated CRP and reduced fat-free mass
when compared to pair-matched healthy controls. Actually,
the association of elevated inflammatory markers and
reduced muscle mass measured by computed tomography
has been observed in HD patients (Kaizu et al., 2003). We
failed to show such correlation in our study. However, the
low sensitive method used for assessing fat-free mass and the
cross-sectional design of this study could be implicated in
the lack of association between CRP and muscle mass.
Another potential catabolic factor, related or not to the
inflammatory process, is the HD procedure per se. A recent
study showed that rates of both whole body and, more
intensively, muscle proteolysis were significantly increased
during HD (Ikizler et al., 2002). In the same study, the
authors found a significant increase in energy expenditure
during the dialysis session and in the subsequent 2 h when
compared to basal (7 and 12%, respectively), suggesting that
because protein synthesis and breakdown are processes that
require energy, part of this energy increase may be due to the
increased protein turnover. The fact this catabolic event is
less exacerbated in a nondialysis day (Veeneman et al., 2004)
could explain the finding of non-increased REE found in the
current study, in which REE was obtained in an interdialytic
period.
High PTH levels have been demonstrated to be associated
with reduced fat-free mass and increased REE in chronic HD
patients (Cuppari et al., 2004). In this recent study, patients
Table 2 Multiple linear regression analysis using REE as dependent
variable in HD group (R2¼0.64)
Coefficient (kcal) P-value 95% CI
Age 5.7 o0.01 9.35 to 2.04
Fat-free mass 20.6 o0.0001 16 to 25.2
PCR 23.6 o0.01 6.4 to 39.7
PTH 0.13 0.02 0.03 to 0.23
Constant 613.5
Abbreviations: CI, confidence interval; HD, hemodialysis; PTH, parathyroid
hormone.
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with severe hyperparathyroidism (defined as PTH X700 pg/
ml) showed markedly increased REE when compared to
patients with lower values of PTH and healthy controls pair
matched for age and gender. Additionally, after para-
thyroidectomy REE decreased significantly (23.1%). PTH
excess has been pointed as exerting toxic effects on various
organs and body systems. Besides bone, several lines of
evidence indicate that skeletal muscle is also a target organ
for PTH. It has been documented that excessive PTH affects
the bioenergetics of skeletal muscle, impairing energy
production, transfer and utilization (Baczynski et al., 1985).
In addition, the hormone may enhance muscle proteolysis
and increase the release of alanine and glutamine in vitro
(Garber, 1983). If we consider that protein catabolism by
circulating PTH may contribute to elevate REE in these
patients, then an association of PTH with muscle parameter
would be expected. However, in our patients no correlation
of PTH with fat-free mass was found. The lack of association
between them could be in part explained by the predomi-
nance of patients with lower PTH observed in our sample, 27
patients (49%) had PTH o200 pg/ml, and other 19 (34.5%)
had mild to moderate levels of PTH (defined as PTH 200–
700 pg/ml), and only nine patients had excessive PTH.
Finally, although PTH and CRP were determinants of REE
in the current study, it is possible that their levels were not
sufficient to determine REE higher than those of controls.
In conclusion, HD patients yielded similar REE with that of
healthy pair-matched controls. Moreover, we demonstrated
that besides the well-recognized determinants of REE such as
fat-free mass and age, frequent condition in CKD such as
secondary hyperparathyroidism and inflammation were
positively associated with REE. As HD patients present
concomitant factors, particular to the disease and the dialysis
procedure, that contribute to both reduction and elevation
of REE, further studies are necessary to evaluate the
hypometabolic and hypermetabolic conditions involving
patients on HD therapy.
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